Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Shuanghe Tianan Pharmaceutical is a specialized Chinese pharmaceutical company focused on the development and manufacturing of treatments for chronic endocrine and cardiovascular diseases. As a core subsidiary of China Resources Double-Crane Pharmaceutical, the company is a leading domestic producer of oral hypoglycemic agents, particularly metformin and sulfonylureas. Its product portfolio includes well-established brands such as Tangshun (metformin hydrochloride) and various formulations of gliclazide and glipizide. The company operates high-standard GMP manufacturing facilities in Beijing and maintains a significant market share in the Chinese diabetes medication sector. Shuanghe Tianan is recognized as a national high-tech enterprise and serves as a key production base for essential medicines within the China Resources Group ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shuanghe Tianan Pharmaceutical.